Increasing Public Awareness and Provider Education about Primary Immunodeficiency Disease

The purpose of the program is to strengthen the nation?s capacity to carry out public health activities in the area of primary immunodeficiency diseases (PID) by increasing and improving physician education and public health awareness for/of PID.

The intent is to disseminate educational information
on a national level to health care providers, educators, third-party payers, impacted families, and others who may help expedite clinical recognition and improve health outcomes for Americans with primary immunodeficiency diseases.

Agency - Department of Health and Human Services

The Department of Health and Human Services is the Federal government's principal agency for protecting the health of all Americans and providing essential human services, especially to those who are least able to help themselves.

Office - See Regional Agency Offices.



Selected Recipients for this Program


RecipientAmount Start DateEnd Date
Modell, Jeffrey Foundation, The $ 3,691,500   2017-08-012022-07-31
$ 0   
$ 0   
$ 0   
$ 0   
$ 0   
$ 0   
$ 0   
$ 0   
$ 0   



Program Accomplishments

Not Applicable.

Uses and Use Restrictions

Grants funds will not be used for research activities. Funding for this grant will be used to reduce the burden of primary immunodeficiency diseases.

Funding for activities should be allocated per the strategy to best meet the short, medium, and long term outcome goals.

Grants funds will not be used for research activities.

Eligibility Requirements

Applicant Eligibility

This FOA will be full and open competition. The ideal applicant will have ten years of experience in: conducting effective physician education and public awareness campaigns for primary immunodeficiency diseases, collaborating effectively with health care and public health partners, and maximizing resources dedicated to campaign materials development and distribution to meet outcome goals.

Beneficiary Eligibility

The general public will benefit from outcome of this FOA. The ideal applicant will have ten years of experience in: conducting effective physician education and public awareness campaigns for primary immunodeficiency diseases, collaborating effectively with health care and public health partners, and maximizing resources dedicated to campaign materials development and distribution to meet outcome goals.

Credentials/Documentation

Applicants are required to include all required documents with their application package at www.grantsolutions.gov. .Costs will be determined in accordance with OMB Circular No A-87 for State and Local governments. For all non-profit grantees, costs will be determined in accordance with the Federal Acquisition Regulations, 48 CFR 31. OMB Circular No. A-87 applies to this program, 2 CRF 200, Subpart E-Cost Principles applies to this program. 2 CFR 200, Subpart E - Cost Principles applies to this program.

Aplication and Award Process

Preapplication Coordination

Preapplication coordination is required.

Environmental impact information is not required for this program.

This program is excluded from coverage under E.O.

12372.

Application Procedures

2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. To apply for this funding opportunity, use guidance listed in the announcement. If you do not have internet, of you have difficulty accessing the forms online, you may contact CDC Office of Grants Services at 770-488-2700.

Award Procedures

Applications will be evaluated for completeness and responsiveness by the agency program and CDC Office of Grant Services (OGS). CDC will not review incomplete and non-responsive applications. After review and approval, a notice of grant award (NoA) will be prepared and processed, along with appropriate notification.

Deadlines

Jul 20, 2017 to Jul 19, 2022

Authorization

Public Health Service Act, 42 USC 247 b (K)(2) , Executive Order 12372.

Range of Approval/Disapproval Time

From 90 to 120 days.

Appeals

Not Applicable.

Renewals

The grant project period is 1 to 5 years. Subject to availability of funds after initial award. Projects may be renewed non-competitively contingent upon satisfactory progress by the recipient (as documented in required reports) and the determination that continued funding is in the best interest of the federal government.

Assistance Considerations

Formula and Matching Requirements

Statutory formulas are not applicable to this program. Matching requirements are not applicable to this program. MOE requirements are not applicable to this program.

Length and Time Phasing of Assistance

Financial assistance is provided for a 12-month budget period with project periods of up to five years subject to the availability of funds and satisfactory progress of the grantee. See FOA announcement for information on how assistance is awarded/released. Grantee should consult OGS for additional information. See the following for information on how assistance is awarded/released: Grantee should consult CDC Office of Grant Services for additional information.

Post Assistance Requirements

Reports

Interim reports from each entity award summarizing the activities undertaken and identifying any sub-grants or sub-contracts awarded to be posted no later than 30 days after the end of each 6-month period.

Congress directed HHS to provide information on activities and programs supported by federal funds.

No cash reports are required.

Federal financial reports are required 90 days after the e end of the project period.

Consult with CDC about performance monitoring activities.

Cash reports are not applicable.

Interim reports from each entity award summarizing the activities undertaken and identifying any sub-grants or sub-contracts awarded to be posted no later than 30 days after the end of each 6-month period.

Congress directed HHS to provide information on activities and programs supported by federal funds.

No cash reports are required.

Federal financial reports are required 90 days after the e end of the project period.

Consult with CDC about performance monitoring activities.

Federal Financial Report (FFR).

Consult with CDC about final reporting requirements.

Interim reports from each entity award summarizing the activities undertaken and identifying any sub-grants or sub-contracts awarded to be posted no later than 30 days after the end of each 6-month period.

Congress directed HHS to provide information on activities and programs supported by federal funds.

No cash reports are required.

Federal financial reports are required 90 days after the e end of the project period.

Consult with CDC about performance monitoring activities. Consult with CDC about performance monitoring requirements.

Audits

In accordance with the provisions of 2 CFR 200, Subpart F - Audit Requirements, non-Federal entities that expend financial assistance of $750,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Non-Federal entities that expend less than $750,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in 2 CFR 200.503. In accordance with the provisions of 2 CFR 200, Subpart F-Audit requirements, non-federal entities that expend financial assistance of $750,0000 or more I federal awards will have a single or program specific audited conducted for that year. Non-federal entities that expend less than $750,000 a year in Federal funds are exempt from Federal audit requirements for that year except as n noted in 2 CFR 200.503.

Records

Consult with CDC Office of Grant Services for information.

Financial Information

Account Identification

75-0959-0-1-550.

Obigations

(Salaries) FY 16 Not Available; FY 17 est $921,500; and FY 18 est $921,500 - FY 2017 Estimated at 921, 500 FY2018 Estimated at 921, 500 FY2019 Estimated at 921, 500 FY2020 Estimated at 921, 500 FY2021 Estimated at 921, 500 Total anticipated funding is $4,607,500. Future funding is subject to availability of funds.

Range and Average of Financial Assistance

FY 2017 Estimated at 921, 500 FY2018 Estimated at 921, 500 FY2019 Estimated at 921, 500 FY2020 Estimated at 921, 500 FY2021 Estimated at 921, 500 Total anticipated funding is $4,607,500. Future funding is subject to availability of funds.

Regulations, Guidelines, and Literature

Not Applicable.

Information Contacts

Regional or Local Office

See Regional Agency Offices.

Headquarters Office

Scott Bowen 1600 Clifton Road, Altanta, Georgia 30329 Email: sbowen1@cdc.gov Phone: 404-498-0068 Fax: 404-498-0140

Criteria for Selecting Proposals

Applicants will be evaluated on the review criteria described in the funding Opportunity Announcement (FOA). In general, the review and selection process of complete and responsive applications to the FOA consists of determination of the scientific and technical merit by objective review panel, availability of funds, and relevance of program priorities and the priorities of DHHS. Refer to the FOA for additional review criteria. The budget is not scored.



Social Entrepreneurship
Spotlight



Girls-Aiding Social Business Accelerators To Help Teen Girls Living In Poverty


Girls-Aiding Social Business Accelerators To Help Teen Girls Living In Poverty

In partnership with the Unreasonable Group, the Nike Foundation is set to launch the Girl Effect Accelerator this November to help social entrepreneurs whose business startups focus on helping economically disadvantaged adolescent girls.




Nonprofit Jobs

  Education Jobs
  Program Director Jobs
  Social Services Jobs
  Program Director Jobs
  Social Services Employment





More Federal Domestic Assistance Programs


Engaging State and Local Emergency Management Agencies to Improve Ability to Prepare for and Respond to All - Hazards Events | Polar Programs | Forestry on Indian Lands | Special Supplemental Nutrition Program for Women, Infants and Children; Nutrition Education Innovations | Assistance to State Water Resources Research Institutes |  Site Style by YAML | Grants.gov | Grants | Grants News | Sitemap | Privacy Policy


Edited by: Michael Saunders

© 2004-2020 Copyright Michael Saunders